Susan DiMaggio is a Senior Director at Alexion, AstraZenecas Rare Disease unit, where she focuses on vendor and alliance management within the Global Drug Safety organization. Her career, which began in private law practice, has been centered on patient and drug safety. Susan holds a JD from Boston University School of Law.
Susans educational background includes a Master of Public Health from the University of Connecticut, indicating a strong foundation and interest in the principles of public health and patient well-being that drive her work in the pharmaceutical industry.
Unique Fact: She has a distinct combination of legal and public health expertise, holding both a JD and an MPH.